Journal profile · PHARMACOLOGY & PHARMACY
Research Journal of Pharmacognosy
ISSN 2345-4458 · eISSN 2345-5977 · Iranian Society of Pharmacognosy · Iran, Islamic Republic of
Research Journal of Pharmacognosy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1 (journal website); fully open access; APC about USD 200; review about 8 weeks (community reports); 26 articles a year; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Research Journal of Pharmacognosy is published by Iranian Society of Pharmacognosy and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Essential Oils and Antimicrobial Activity, Plant Ecology and Taxonomy Studies and Acute Lymphoblastic Leukemia research, together about 42.9% of its articles. Its main subfields are Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
Research Journal of Pharmacognosy (RJP) is an Open Access journal published quarterly by the Iranian Society of Pharmacognosy that welcomes manuscripts covering all areas of natural products including pharmacognosy, natural product chemistry, bioassay, structure-activity relationship, analytical methods, as well as traditional pharmacy, ethno-pharmacology, clinical studies, medicinal foods, systems biology, herbal cell culture and plant biotechnology. Manuscripts will be subjected to peer-review while authors may suggest qualified referees.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Maryam Hamzeloo-MoghadamPublisher website
Editorial board by country: none in mainland China; most named Iran 20, Macau, China 1, India 1, Italy 1, Canada 1 (29 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences21.4%
- Plant Ecology and Taxonomy StudiesAgricultural and Biological Sciences14.3%
- Acute Lymphoblastic Leukemia researchMedicine7.1%
- Light effects on plantsAgricultural and Biological Sciences7.1%
- Sesquiterpenes and Asteraceae StudiesBiochemistry, Genetics and Molecular Biology7.1%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences7.1%
- Natural Compound Pharmacology StudiesAgricultural and Biological Sciences7.1%
- Pharmaceutical studies and practicesMedicine7.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASPublisher website
Other: Google Scholar, EBSCO, ISI, ISC, SID, Magiran
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1Publisher website ·
- CiteScore 2026-06
- 1.9LetPub ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.32LetPub ·
- h-index
- 1OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 10%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 26LetPub ·
Articles by year OpenAlex count · 6 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2021 | 1 | 1 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | IRR 25,000,000 / USD 200 | No | CC BY-NC | |
| OpenAlex | IRR 5,000,000 | — | — | |
| LetPub | USD 100 / IRR 12,000,000 | No | — | |
| Publisher website | EUR 170 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- case reportsTypes of contributions Letter to editor Short communications Case reports Original papers ReviewsLength not stated
- letter to editorTypes of contributions Letter to editor Short communications Case reports Original papers ReviewsLength not stated
- original papersTypes of contributions Letter to editor Short communications Case reports Original papers ReviewsLength not stated
- reviewsTypes of contributions Letter to editor Short communications Case reports Original papers ReviewsLength not stated
- short communicationsTypes of contributions Letter to editor Short communications Case reports Original papers ReviewsLength not stated
Policy excerpts from the journal's websiteAI use, Publication ethics, License & copyright, Peer review, Plagiarism
- AI use AI use
AI software use must be declared and explained before acknowledgments section. Model summary
As clarified by COPE: "Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent in disclosing in the Materials and Methods (or similar section) of the paper how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even t…
Source ↗Publisher website ·- Publication ethics
Editorial policy in accordance with COPE code of conduct and best practices. Model summary
Research Journal of Pharmacognosy (RJP) editorial policy is in accordance with code of conduct and best practices by COPE.
Source ↗Publisher website ·- License & copyright
Copyright retained by authors; articles licensed under Creative Commons Attribution-NonCommercial 4.0 International License. Model summary
The copyright of the articles published in Research Journal of Pharmacognosy (RJP) retains to the authors and authors are free to reproduce and disseminate their work. The articles published in Research Journal of Pharmacognosy (RJP) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Source ↗Publisher website ·- Peer review
Submitted manuscripts undergo peer review by experts in related fields. Model summary
Submitted manuscripts will be subjected to peer-review process by experts in the related fields to evaluate the suitability for publication in RJP.
Source ↗Publisher website ·- Plagiarism
Manuscripts checked for plagiarism by plagiarism check software. Model summary
The submitted manuscript will be checked for plagiarism by plagiarism check software.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Iranian Society of Pharmacognosy
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2345-4458
- Electronic ISSN
- 2345-5977
- Latest issue on the website
- Volume 13 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Research Journal of Pharmacognosy
What CAS zone is Research Journal of Pharmacognosy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Research Journal of Pharmacognosy is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Research Journal of Pharmacognosy?
The journal's website gives an impact factor of 1; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.9, h-index 1.
How long does peer review take at Research Journal of Pharmacognosy?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Research Journal of Pharmacognosy based?
Of the 29 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (20), Macau, China (1) and India (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Research Journal of Pharmacognosy?
According to LetPub and DOAJ records, Research Journal of Pharmacognosy is indexed in ESCI, Scopus and DOAJ. The journal's website also lists CAS; that list has not been checked against each database.
Is Research Journal of Pharmacognosy open access, and what is the APC?
Research Journal of Pharmacognosy is a fully open-access journal. APC about USD 200.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .